Replacing, Removing, or Upgrading Underground Storage Tanks Loan

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as dietary supplements), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. Under this NOFO, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. This NOFO will provide up to three years (R61 phase) of support for milestone-driven testing of pharmacokinetics, bioavailability, and assessment of the natural products effect (i.e., measure of mechanism of action) when used by humans on a specified target measure. If milestones in the R61 phase are achieved, up to 3 years of additional support (R33 phase) may be awarded to replicate the impact of the natural product on target engagement(s) when used by humans and assess whether there is an association between the degree of the impact on the target engagement and clinical outcomes in a participant population. Applications are encouraged to design R33 studies to determine how to optimize the impact of the natural product on the target engagement by optimizing the delivery of the natural product through examination of different doses or formulations. In addition, applications can be designed to combine the natural product with another treatment approach that is known to impact the same target engagement measure; or study the impact of the natural product in a population that is more responsive,

The Rhode Island Lift Program is a strategic investment initiative designed to fuel the growth and successful capital raise of high-impact life sciences companies in Rhode Island. This competitive program provides a non-dilutive funding boost to companies that have finalized or recently closed a funding round. By offering this last infusion of capital, the program helps high-potential life sciences ventures scale their operations, drive innovation, and strengthen their impact on the state’s economy, industry growth, and patient outcomes. Through this support, Rhode Island continues to position itself as a leader in life sciences advancement and commercialization.

The Innovate Alabama Supplemental Grant Program provides additional resources for small businesses whose proven business models and technologies are helping accelerate innovation in the state. Small businesses who have an active Phase I or Phase II Federal Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) grant are eligible for non-dilutive funding from the Innovate Alabama Supplemental Grant Program. This unique grant program provides support for recipients who do not need to exchange shares of their company for the grant. These businesses have proven through scientific review that their technologies are viable, valuable and scalable.

The Small Business Incentive Program offers up to $5,000 for Santa Ana Businesses with 5 or less employees (including the owners) during the first three years in business. Funds are granted as a reimbursement for eligible business expenses. Businesses must be able to provide proof (receipts) for those expenses.

She's Connected by AT&T is open to U.S.-based small-businesses that are women-owned and have fewer than 51 employees. The grand prize winner will receive a $50,000 grant and a year of free AT&T service alongside a new device. Four runner-up businesses will receive $5,000 microgrants.